DNA

Daily

How healthy is your DNA? This biotech is crowdfunding a way to let you know

DNA is damaged and broken every day, sometimes naturally and sometimes as a result of exposure to ultraviolet and other kinds of radiation and chemical toxins. But sometimes it can’t be repaired. DNA damage and poor repair capabilities have been linked to some cancers, immunological diseases and premature aging. A startup called Exogen Biotechnology is […]

Devices & Diagnostics

How your DNA may write your next drug prescription

In the back seat of a taxi, on the way home from oral arguments in the AMP v. Myriad Genetics Supreme Court case, Chris Mason and Jeffrey Rosenfeld decided to start a company. Mason, a faculty member at Weill Cornell Medical School and an affiliate of Yale University, had provided expert witness testimony to the […]

presented by
Diagnostics

New molecular test in clinical trials could help physicians identify multiple sclerosis earlier

About 400,000 Americans have multiple sclerosis, a chronic central nervous system disease that can cause blurred vision, poor coordination, slurred speech, numbness and paralysis, among other things. Despite the serious symptoms, diagnosis is often tricky because symptoms vary and can be hard for physicians to interpret. Gaithersburg, Maryland company DioGenix Inc. started up in 2008 […]

News

LabCorp completes $85M acquisition of Orchid Cellmark

LabCorp (NYSE:LH), after waiting eight months for regulators’ blessings, had a speedy wrap up of its $85 million acquisition of DNA testing company Orchid Cellmark. Laboratory testing and diagnostics firm LabCorp  secured the greater than 90 percent of shares in Orchid that allowed the company to proceed with a short-form merger, meaning the deal could […]